PTC Therapeutics, Inc. (NASDAQ:PTCT), a biopharmaceutical company focused on developing and commercializing novel medicines for rare disorders, finds itself at a critical juncture. With a promising ...

This gene makes people sensitive to some bitter chemicals, such as phenylthiocarbamide (PTC) and propylthiouracil (PROP).

Have you ever wondered why some people cannot stand bitter foods like kale, broccoli, black coffee or dark chocolate, while ...

Inc., a leading provider of software solutions for product design, manufacturing, and service, continues to navigate a challenging macroeconomic environment while positioning itself for future growth.

The stock's fall snapped a two-day winning streak.

PTC Therapeutics (PTCT) is advancing 8% after investment bank Cantor Fitzgerald’ hiked its price target on the drug maker’s ...

Cantor Fitzgerald raised the firm’s price target on PTC Therapeutics (PTCT) to $113 from $76 and keeps an Overweight rating on the shares. PTC ...

The Greek island of Santorini remains on high alert as earthquake tremors persist for the fourth consecutive day, prompting ...

Actor-politician says, 'Bodies of those who died in the stampede have been thrown into the river, polluting the water' ...

PTC Punjabi dominated UK Asian TV ratings on Sunday, while Utsav Plus and Sony TV shared the No.2 spot, according to exclusive data obtained by BizAsiaLive.com.

Barclays analyst Saket Kalia maintained a Buy rating on PTC (PTC – Research Report) today and set a price target of $215.00. The company’s ...

The Western US solar fleet is amid rapid growth, with the region being home to four of the top five markets in planned ...